Instructions to Authors

Instructions to Authors

Instructions to Authors About the Journal Archiv der Pharmazie – Chemistry in Life Sciences (Arch. Pharm. Chem. Life Sci.) is an international journal devoted to research and development in all fields of pharmaceutical and medicinal chemistry. Emphasis is put on papers combining synthetic organic chemistry, structural biology, molecular modeling, bioorganic chemistry, natural products chemistry, biochemistry or analytical methods with pharmaceutical or medicinal aspects such as biological activity. The emphasis of this journal is put on original research papers, reviews/mini-reviews and short communications. Other scientifically valuable contributions, e. g. highlights, symposia contributions, discussions, and essays are also welcome at the discretion of the Editor-in-Chief. All manuscripts which are suitable of publication in the journal will be peer-reviewed. Editorial Policies The submitting author vouches that the work has not been published elsewhere, either completely, in part, or in any other form and that the manuscript has not been submitted to another journal. The submitting author (listed under “Correspondence”) accepts the responsibility of having included as co- authors all persons appropriate and none inappropriate. The submitting author certifies that all co- authors have seen a draft copy of the manuscript and agree with its publication. If a manuscript was previously submitted to ChemMedChem, then please state the manuscript number of the previous submission in the cover letter. This will help to speed up the peer-review process. Online publication Effective with the 2015 volume Archiv der Pharmazie is published in online-only format. Published articles continue to be disseminated quickly through the journal’s broad network of indexing services, including ISI, MEDLINE and Scopus. Articles also continue to be discoverable through popular search engines such as Google. All color images are reproduced digitally and are published free of charge. elocators eLocators are unique identifiers for an article that serve the same function page numbers have traditionally served in the print world. The use of eLocators supports Wiley’s transition from print, page-based publication workflows to a modern, web-first environment that reflects the future of journal publishing. As of the 2017 volume Archiv der Pharmazie is using eLocators instead of page numbers. The eLocator will become the primary means of citation, just as page numbers have been in the past – a readable and meaningful citation reference. Every article will now have a unique identifier (eLocator) instead of a page number. The eLocator appears as the last identifier (e.g. e172819) in a citation, replacing the page number. Because we are moving to a web-first publication workflow, citations will no longer be derived from print terminology. ArchPharm_December 2016 1 The standardization of the How-To-Cite style will not impact the journal’s reference style which can continue to follow the current style applied in proofs but using the eLocator instead of the page numbers, e.g.: R. Kiss, D. Bajusz, R. Baskin, K. Tóth, K. Monostory, P.P. Sayeski, G.M. Keserü, Arch Pharm. Chem. Life Sci. 2016, 349, e1600246, DOI: 10.1002/ardp.201600246 Please note that in addition to the eLocator, PDF versions of online-only articles will include pagination for ease of reference when printed. These numbers will be self-contained and discrete to each article. The PDF page numbers will not be “running” or continue consecutively from article to article throughout an issue but will always start with 1 to xx. These page numbers should NOT be used in the citation. For more information on how to cite please go to section “Preparation of manuscripts”. Submission System Archiv der Pharmazie – Chemistry in Life Sciences offers a web-based manuscript submission and peer review system at http://mc.manuscriptcentral.com/archpharm. This service guarantees fast and safe submission of manuscripts and a rapid assessment process. Usage of this system is mandatory – exceptions can only be made in fully justified cases. To submit your manuscript online, please proceed along the following steps: • Prepare your manuscript and illustrations in the appropriate format, according to the instructions given below. Please also make sure that your paper conforms to the scientific and style instructions of Archiv der Pharmazie – Chemistry in Life Sciences as given herein. You can also find a link to these instructions at the submission site on the homepage of the journal at http://www.archpharm.com under the link “For Contributors”. • If you have not already done so, create an account for yourself in the system at the submission site http://mc.manuscriptcentral.com/archpharm by clicking on the “Create an Account” button. To monitor the progress of your manuscript throughout the review process, just login periodically and check your Author Center. • Please be sure to study the “Instructions and Forms” given on the Archiv der Pharmazie – Chemistry in Life Sciences homepage carefully, and then let the system guide you through the submission process. Online help is available to you at all times during the process. You are also able to exit/re-enter at any stage before finally “submitting” your work. All submissions are kept strictly confidential. If you have any questions concerning the online submission program, do not hesitate to contact the editorial support at [email protected] • As of 2015 the journal will no longer be printed. All color images will then be reproduced digitally and published free of charge. • Manuscripts files should have margins of 2 cm and be 1.5-line spaced. Please avoid Far- Eastern symbols. Please number each page of the manuscript consecutively, starting with the title page. ArchPharm_December 2016 2 • Copies of manuscripts to be published or submitted elsewhere must be included, if their content impinges on the results in the present manuscript. • All contributions are subject to refereeing. Authors may suggest up to four potential referees (give complete addresses, fax and e-mail numbers). They may also list individuals who they wish to be excluded from the review process. The corresponding author will be immediately informed of acceptance, need for revision or rejection. • A revised paper will retain its original date of receipt only if it is resubmitted within three months after revision was requested. Responsibility for the factual accuracy of a paper rests entirely with the author. • The editorial staff reserves the right to edit the manuscript. • After acceptance you will be prompted to login to Wiley Author Licensing Services (WALS) and to complete the copyright license agreement on behalf of all authors on the paper. • Before publication the corresponding author receives galley proofs for the sole purpose of correcting misprints and/or absolutely necessary corrections. Proofs will be sent as a zipped pdf file directly by the typesetter. Corrections must be returned within 48 hours. Checking of proofs is solely the author’s responsibility. Pre-submission Language Editing Services: • For non-native English speakers Wiley provides pre-submission professional language and manuscript editing services. Services include English language editing, translations, manuscript formatting and figure preparation. The following website details the services offered: http://wileyeditingservices.com/en/. Types of Papers 1) Research papers Research papers consist of experimental and theoretical work with new results in the topics given in Section 2. Research papers should not exceed 7 printed pages (equivalent to a total of 44 000 characters). In addition, up to 8 figures and tables may be included. 2) Short communications Short communications should contain novel experimental or theoretical results in need of urgent publication. Please add the term “Short Communication” below the title. A short communication contains a summary and should not exceed 4 printed pages (including Tables, Figures and References). The same manuscript organization as described under Section 3.1 applies. 3) Reviews Reviews are comprehensive critical descriptions on present knowledge of actual research subjects or technological developments. Please add the term “Review” below the title. Section division is left to the author(s), otherwise criteria of Section 3.1 apply. The length of review articles should not exceed printed 9–10 pages (equivalent to a total of 60 000 characters). Reviews are frequently submitted by invitation. They are, of course, also welcome from other authors. ArchPharm_December 2016 3 Preparation of Manuscripts Manuscript should be organized as follows: First page The first page of the manuscript contains the following items: • The title of the paper. Titles should be concise, informative and contain about 12 words. Please capitalize nouns, verbs and adjectives. Also, please avoid abbreviations. • The full names (including first name spelled out) of authors and the name of the institution or company. If the publication originates from authors of different affiliations, they should be clearly stated by using superscript letters. • Name and full postal address, including phone, fax and e-mail numbers, of the author to whom all correspondence (including galley proofs) should be sent. • Up to 5 key words which will be used for compiling the subject index. Summary Starting with page 2 a summary should be given. The summary should not exceed 200 words and should give scientific rationale, results and

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    9 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us